Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II.

Favaloro, Emmanuel J; Lippi, Giuseppe

Favaloro, Emmanuel J; Lippi, Giuseppe.

Favaloro EJ; Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, Westmead, Australia.
Lippi G; Section of Clinical Biochemistry, University of Verona, Verona, Italy.

Semin Thromb Hemost ; 47(4): 333-337, 2021 06.

Article in English | MEDLINE | ID: covidwho-1272870

Subject(s)

Anticoagulants/therapeutic use; COVID-19/blood; Hemostasis/physiology; SARS-CoV-2; Thrombophilia/etiology; Thrombosis/prevention & control; Anticoagulants/adverse effects; COVID-19/complications; Hemostasis/drug effects; Humans; Thrombophilia/drug therapy; Thrombosis/etiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / Thrombophilia / SARS-CoV-2 / COVID-19 / Hemostasis / Anticoagulants Topics: Long Covid Limits: Humans Language: English Journal: Semin Thromb Hemost Year: 2021 Document Type: Article Affiliation country: S-0041-1728775

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google